EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19

Benedikt Strunz iD, Christopher Maucourant, Adi Mehta, Hui Wan, Likun Du, Dan Sun, Puran Chen, Anna Nordlander, Yu Gao, Martin Cornillet, Jonna Bister, Egle Kvedaraite und 15 weitere

The Journal of Infectious Diseases · 16.08.2024 · 230 (2) · e318-e326

DOI: 10.1093/infdis/jiae036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 29.02.2024. Verfasst von Benedikt Strunz und 26 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: COVID-19, Interferon Type I, Autoantibodies, SARS-CoV-2. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, European Union Horizon 2020, Swedish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to severe disease with increased morbidity and mortality among certain risk groups. The presence of autoantibodies against type I interferons (aIFN-Abs) is one mechanism that contributes to severe coronavirus disease 2019 (COVID-19).

Methods

This study aimed to investigate the presence of aIFN-Abs in relation to the soluble proteome, circulating immune cell numbers, and cellular phenotypes, as well as development of adaptive immunity. Results aIFN-Abs were more prevalent in critical compared to severe COVID-19 but largely absent in the other viral and bacterial infections studied here. The antibody and T-cell response to SARS-CoV-2 remained largely unaffected by the presence aIFN-Abs. Similarly, the inflammatory response in COVID-19 was comparable in individuals with and without aIFN-Abs. Instead, presence of aIFN-Abs had an impact on cellular immune system composition and skewing of cellular immune pathways.

Conclusions

Our data suggest that aIFN-Abs do not significantly influence development of adaptive immunity but covary with alterations in immune cell numbers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Interferon Type IAutoantibodiesSARS-CoV-2HumansMaleFemaleMiddle AgedImmunity, CellularAdultAgedAdaptive ImmunityT-LymphocytesSeverity of Illness Index

Stichwörter der Autor:innen

COVID-19autoantibodiesimmunityinterferon

Substanzen

Interferon Type IAutoantibodies

Autor:innen und Institutionen

  • Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
  • Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Benedikt Strunz, Niklas K Björkström

Förderung

  • European Research Council
  • European Union Horizon 2020
  • Swedish Research Council
  • Swedish Cancer Society
  • Swedish Society for Medical Research
  • Swedish Foundation for Strategic Research
  • Knut and Alice Wallenberg Foundation
  • Novo Nordisk Foundation

Zitieren

APA

Strunz, B., Maucourant, C., Mehta, A., Wan, H., Du, L., Sun, D., Chen, P., Nordlander, A., Gao, Y., Cornillet, M., Bister, J., Kvedaraite, E., Christ, W., Klingström, J., Geanon, D., Parke, Å., Ekwall-Larson, A., Rivino, L., MacAry, P. A., …, & Karolinska KI/K COVID-19 Study Group (2024). Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19. The Journal of Infectious Diseases, 230(2), e318-e326. https://doi.org/10.1093/infdis/jiae036

Vancouver

Strunz B, Maucourant C, Mehta A, Wan H, Du L, Sun D, et al. Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19. The Journal of Infectious Diseases. 2024;230(2):e318-e326. doi:10.1093/infdis/jiae036

BibTeX
@article{Strunz2024,
  author = {Strunz, Benedikt and Maucourant, Christopher and Mehta, Adi and Wan, Hui and Du, Likun and Sun, Dan and Chen, Puran and Nordlander, Anna and Gao, Yu and Cornillet, Martin and Bister, Jonna and Kvedaraite, Egle and Christ, Wanda and Klingström, Jonas and Geanon, Daniel and Parke, Åsa and Ekwall-Larson, Anna and Rivino, Laura and MacAry, Paul A and Aleman, Soo and Buggert, Marcus and Ljunggren, Hans-Gustaf and Pan-Hammarström, Qiang and Lund-Johansen, Fridtjof and Strålin, Kristoffer and Björkström, Niklas K and Karolinska KI/K COVID-19 Study Group, Karolinska KI/K COVID-19 Study Group},
  title = {Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  volume = {230},
  number = {2},
  pages = {e318--e326},
  doi = {10.1093/infdis/jiae036}
}
Kostenlos starten →